Cargando…
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors
This study compared the bioavailability of two pimitespib formulations (Formulations A and B), evaluated the food effect on Formulation A, and evaluated the safety and efficacy of multiple pimitespib doses in patients with solid tumors. This clinical, pharmacological multicenter study had two cohort...
Autores principales: | Komatsu, Yoshito, Shimokawa, Tsuneo, Akiyoshi, Kohei, Karayama, Masato, Shimomura, Akihiko, Kawamoto, Yasuyuki, Yuki, Satoshi, Tambo, Yuichi, Kasahara, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395490/ https://www.ncbi.nlm.nih.gov/pubmed/35932386 http://dx.doi.org/10.1007/s10637-022-01285-9 |
Ejemplares similares
-
TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia
por: Ikebe, Emi, et al.
Publicado: (2021) -
Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report
por: Teranishi, Ryugo, et al.
Publicado: (2023) -
Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study
por: Fança-Berthon, Pascale, et al.
Publicado: (2021) -
The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two‐Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers
por: Shibata, Mai, et al.
Publicado: (2020) -
Vortex dynamics in the two-dimensional BCS-BEC crossover
por: Heyl, Max, et al.
Publicado: (2022)